MedPath

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Phase 3
Completed
Conditions
Atrial Fibrillation
Atrial Flutter
Registration Number
NCT00126022
Lead Sponsor
Solvay Pharmaceuticals
Brief Summary

The purpose of this study is to demonstrate the ability of tedisamil to convert atrial fibrillation or flutter into normal sinus rhythm (NSR) in female patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Willing to sign informed consent before screening examinations are performed and before the study drug is administered
  • Females > 18 years of age
  • Subjects with documented (60 second rhythm strip) symptomatic atrial fibrillation or flutter (duration > 3 hours and < 45 days) at the time of randomization
  • Subjects who are in no distress and hemodynamically stable (supine systolic blood pressure > 90 mmHg and diastolic blood pressure < 105 mmHg)
Exclusion Criteria
  • Pregnancy and lactation
  • Acute myocardial infarction and cerebrovascular accidents
  • Coronary syndromes and congestive heart failure (CHF) New York Heart Association (NYHA) IV
  • Life-threatening ventricular arrhythmias and electrocardiogram (ECG) abnormalities
  • Concurrent antiarrhythmic treatments

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (81)

Site 33

🇵🇱

Szczecin, Poland

Site 37

🇷🇴

Tg. Mures, Romania

Site 22

🇮🇱

Jerusalem, Israel

Site 56

Niska Banja, Former Serbia and Montenegro

Site 15

🇩🇪

Bad Nauheim, Germany

Site 38

🇷🇴

Brasov, Romania

Site 30

🇵🇱

Lodz, Poland

Site 29

🇵🇱

Lublin, Poland

Site 35

🇵🇱

Wroclaw, Poland

Site 16

🇩🇪

Halle, Germany

Site 39

🇷🇴

Bucharest, Romania

Site 24

🇵🇱

Warszawa, Poland

Site 34

🇵🇱

Wroclaw, Poland

Site 77

🇺🇦

Kiev, Ukraine

Site 23

🇮🇱

Jerusalem, Israel

Site 58

Belgrade, Former Serbia and Montenegro

Site 55

Sremska Kamenica, Former Serbia and Montenegro

Site 41

🇷🇺

Moscow, Russian Federation

Site 46

🇷🇺

Moscow, Russian Federation

Site 20

🇮🇱

Tel-Aviv, Israel

Site 79

🇺🇦

Zaporizhya, Ukraine

Site 60

🇸🇰

Banska Bystrica, Slovakia

Site 27

🇵🇱

Warszawa, Poland

Site 72

🇺🇦

Donetsk, Ukraine

Site 42

🇷🇺

Moscow, Russian Federation

Site 18

🇮🇱

Haifa, Israel

Site 45

🇷🇺

Moscow, Russian Federation

Site 48

🇷🇺

Moscow, Russian Federation

Site 21

🇮🇱

Tel-Aviv, Israel

Site 50

🇷🇺

St. Petersburg, Russian Federation

Site 59

🇸🇰

Nitra, Slovakia

Site 63

🇸🇰

Presov, Slovakia

Site 17

🇩🇪

Gottingen, Germany

Site 26

🇵🇱

Bydgoszcz, Poland

Site 44

🇷🇺

Moscow, Russian Federation

Site 47

🇷🇺

Moscow, Russian Federation

Site 19

🇮🇱

Jerusalem, Israel

Site 40

🇷🇴

Bucharest, Romania

Site 43

🇷🇺

Moscow, Russian Federation

Site 32

🇵🇱

Bydgoszcz, Poland

Site 36

🇵🇱

Lublin, Poland

Site 31

🇵🇱

Medyczna, Poland

Site 25

🇵🇱

Warszawa, Poland

Site 71

🇺🇦

Donetsk, Ukraine

Site 28

🇵🇱

Warszawa, Poland

Site 73

🇺🇦

Kiev, Ukraine

Site 74

🇺🇦

Lviv, Ukraine

Site 49

🇷🇺

Moscow, Russian Federation

Site 68

🇺🇦

Dnepropetrovsk, Ukraine

Site 64

🇸🇰

Bratislava, Slovakia

Site 61

🇸🇰

Kosice, Slovakia

Site 69

🇺🇦

Dnepropetrovsk, Ukraine

Site 75

🇺🇦

Kharkiv, Ukraine

Site 70

🇺🇦

Kiev, Ukraine

Site 78

🇺🇦

Zaporozhye, Ukraine

Site 62

🇸🇰

Lucenec, Slovakia

Site 65

🇸🇰

Nove Zamky, Slovakia

Site 2

🇦🇷

Buenos Aires, Argentina

Site 82

🇺🇸

Tullahoma, Tennessee, United States

Site 3

🇦🇷

Buenos Aires, Argentina

Site 4

🇦🇷

Tucuman, Argentina

Site 5

🇦🇷

Munro, Argentina

Site 8

🇨🇿

Brno, Czech Republic

Site 11

🇨🇿

Jindrichuv Hradec, Czech Republic

Site 9

🇨🇿

Ostrava-Poruba, Czech Republic

Site 10

🇨🇿

Plzen, Czech Republic

Site 14

🇨🇿

Prague, Czech Republic

Site 6

🇨🇿

Prague, Czech Republic

Site 7

🇨🇿

Prague, Czech Republic

Site 12

🇨🇿

Slany, Czech Republic

Site 52

Belgrade, Former Serbia and Montenegro

Site 13

🇨🇿

Usti nad Orlici, Czech Republic

Site 53

Belgrade, Former Serbia and Montenegro

Site 54

Belgrade, Former Serbia and Montenegro

Site 51

🇷🇺

Moscow, Russian Federation

Site 57

Belgrade, Former Serbia and Montenegro

Site 81

🇬🇧

London, United Kingdom

Site 66

🇿🇦

Cape Town, South Africa

Site 67

🇿🇦

Cape Town, South Africa

Site 80

🇺🇦

Odessa, Ukraine

Site 76

🇺🇦

Kiev, Ukraine

© Copyright 2025. All Rights Reserved by MedPath